Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4Qing Luo, Yongxiang Yin|Breast Cancer Research|2025Cited by 4